US Broker Ratings

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Exploring an 84% Potential Upside in Biotechnology

Bicara Therapeutics Inc. (BCAX) has emerged as a noteworthy player in the biotechnology sector, given its promising pipeline and considerable market potential. This Boston-based clinical-stage biopharmaceutical company is focused on..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

Weave Communications, Inc. (WEAV) Stock Report: Analyzing a 51.79% Potential Upside in Healthcare Tech

Weave Communications, Inc. (NASDAQ: WEAV) has been making waves in the healthcare technology sector, offering a robust software platform tailored for small and medium-sized businesses. With a market capitalization of..

RxSight, Inc. (RXST) Stock Analysis: Insights into Its Market Position and Growth Prospects

RxSight, Inc. (NASDAQ: RXST), a pioneering player in the healthcare sector, is carving a niche in the medical devices industry with its innovative Light Adjustable Lens (LAL) technology. The company’s..

CareDx, Inc. (CDNA) Stock Analysis: A Healthcare Innovator with a 6.95% Upside Potential

Investors eyeing opportunities in the healthcare sector might find CareDx, Inc. (NASDAQ: CDNA) an intriguing proposition. This U.S.-based company is making waves in the field of diagnostics and research, particularly..

InMode Ltd. (INMD) Stock Analysis: Exploring a 18.15% Potential Upside in the Medical Devices Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specifically in the medical devices industry, offers a compelling investment opportunity for those looking at the intersection of technology..

STAAR Surgical Company (STAA) Stock Analysis: Exploring a 21.45% Potential Upside in the Healthcare Sector

For investors with a keen interest in the healthcare sector, STAAR Surgical Company (NASDAQ: STAA) presents a fascinating opportunity. With a rich history dating back to 1982 and a focus..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: A Biotech with 57% Upside Potential

For investors seeking opportunities in the biotechnology sector, Nurix Therapeutics, Inc. (NASDAQ: NRIX) presents a compelling case. This San Francisco-based clinical-stage biopharmaceutical company is at the forefront of discovering and..

AMN Healthcare Services Inc (AMN) Stock Analysis: Explore the 7.18% Potential Upside Amidst Sector Volatility

As the healthcare industry continues to grapple with unprecedented challenges, AMN Healthcare Services Inc (NYSE: AMN) stands as a noteworthy player, offering a blend of workforce solutions and staffing services..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Play with 64% Potential Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN) is capturing the attention of investors in the biotechnology sector with its promising pipeline and compelling market dynamics. Headquartered in Boulder, Colorado, the clinical-stage biopharmaceutical..

CureVac N.V. (CVAC) Investor Outlook: Navigating a Post-Acquisition Era in mRNA Biotechnology

CureVac N.V. (NASDAQ: CVAC), a prominent player in the mRNA biotechnology sector, has been under the spotlight following its acquisition by BioNTech SE as of December 18, 2025. This strategic..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: A 69.88% Potential Upside Sparks Investor Interest

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical stage biotechnology company, is making waves in the healthcare sector with its ambitious focus on developing therapeutics for inflammatory bowel disease (IBD). With..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring a Potential 150% Upside for Investors

Niagen Bioscience, Inc. (NAGE), operating in the rapidly evolving biotechnology sector, presents a compelling investment thesis with its strong growth potential and notable market positioning. Headquartered in Los Angeles, California,..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Growth Potential Amidst Strong Revenue Performance

Phibro Animal Health Corporation (NASDAQ: PAHC), a stalwart in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, has been capturing investor attention with its robust revenue..

Ardelyx, Inc. (ARDX) Stock Analysis: Exploring 87.5% Potential Upside in Biotech

Ardelyx, Inc. (NASDAQ: ARDX) is making waves in the biotechnology sector with its innovative approach to treating unmet medical needs. Headquartered in Waltham, Massachusetts, Ardelyx has captured investor attention, not..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 52% Potential Upside

For investors with a keen eye on the healthcare sector, Nutex Health Inc. (NASDAQ: NUTX) presents a compelling opportunity, boasting a market capitalization of $1.16 billion. As a prominent player..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Riding a 24.97% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is attracting considerable attention from investors due to its compelling growth prospects and robust operational framework. With..

NeoGenomics, Inc. (NEO) Stock Analysis: Assessing a 16.59% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO) is garnering attention in the investment community with a promising 16.59% potential upside, according to recent analyst ratings. With its market cap standing at $1.62 billion,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Gem with 129% Upside Potential

Wave Life Sciences Ltd. (NASDAQ: WVE) is a trailblazing entity in the biotechnology sector, operating out of Singapore with a focus on innovative RNA medicines. As the market cap of..

Evolent Health, Inc. (EVH) Stock Analysis: A 131% Potential Upside Amidst Sector Challenges

Evolent Health, Inc. (NYSE: EVH), a prominent player in the healthcare sector, specifically in health information services, has captured investor attention with an impressive potential upside of 131.33%. Despite recent..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds